Bistline, K. L., & Sinanovic, E. (2018). Does the inclusion of the cost and burden of adverse drug reactions associated with drug-resistant TB treatment affect the incremental cost-effectiveness of new treatment regimens? A case study from the introduction of bedaquiline in South Africa National TB Programme. Department of Public Health and Family Medicine.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
Bistline, Kathryn Lou, and Edina Sinanovic. Does the Inclusion of the Cost and Burden of Adverse Drug Reactions Associated with Drug-resistant TB Treatment Affect the Incremental Cost-effectiveness of New Treatment Regimens? A Case Study from the Introduction of Bedaquiline in South Africa National TB Programme. Department of Public Health and Family Medicine, 2018.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
Bistline, Kathryn Lou, and Edina Sinanovic. Does the Inclusion of the Cost and Burden of Adverse Drug Reactions Associated with Drug-resistant TB Treatment Affect the Incremental Cost-effectiveness of New Treatment Regimens? A Case Study from the Introduction of Bedaquiline in South Africa National TB Programme. Department of Public Health and Family Medicine, 2018.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.